Swiss Healthtech Stock News

As European markets show mixed macroeconomic data and a modest rise in major indexes, investors are increasingly looking for opportunities in stocks that may be undervalued relative to their intrinsic value. In such an environment, identifying companies with strong fundamentals and stable financials can provide potential avenues for growth as the market seeks stability amid economic fluctuations.

Sandoz Group AG has opened a fully digitally integrated, US$99 million biosimilar development centre in Ljubljana, Slovenia, spanning about 10,000 m² and employing more than 200 scientists as part of its plan to build an end-to-end European biosimilar hub. The facility’s integration with sites in Germany, the UK, Slovenia and the recently acquired Toulouse, France, biosimilar plant highlights Sandoz’s push to bring more biosimilar development and manufacturing in-house across its European...

Idorsia (SWX:IDIA) has agreed to a senior secured term loan of up to CHF 250 million with funds managed by Pharmakon Advisors, refinancing its existing New Money Facility and removing near term debt maturities. See our latest analysis for Idorsia. Idorsia's debt refinancing news lands after a sharp shift in sentiment, with the 90 day share price return of 84.34% and 1 year total shareholder return of 208.23% contrasting with weaker 3 and 5 year total shareholder returns. This suggests...

Vontobel Holding (SWX:VONN) has opened a new office in Los Angeles, a step that extends its US footprint and brings its Swiss Financial Advisers business closer to American clients seeking international diversification. See our latest analysis for Vontobel Holding. The Los Angeles opening comes as Vontobel Holding’s share price sits at CHF72.3, with a 30-day share price return of 4.63% and a 1-year total shareholder return of 21.13%, which may indicate building momentum compared with earlier...

PolyPeptide Group (SWX:PPGN) has attracted fresh attention after swinging from a net loss to a net profit in its latest quarter, a shift that coincides with supportive analyst sentiment. See our latest analysis for PolyPeptide Group. The recent swing to profit appears to have coincided with a sharp improvement in sentiment, with PolyPeptide Group’s share price at CHF39.35 delivering a 59.96% 90 day share price return and a 98.14% 1 year total shareholder return, even though the 5 year total...

Zug Estates Holding AG recently completed the placement of a CHF 100,000,000 seven-year green bond with a 1.35% fixed coupon, intending to list it on the SIX Swiss Exchange and use the proceeds to refinance projects under its Green Finance Framework. This transaction expands Zug Estates’ sustainable financing base and highlights ongoing investor appetite for real estate issuers that align funding with transparent environmental criteria. We’ll now examine how this green bond issuance, and its...

Siegfried Holding (SWX:SFZN) has opened a new large scale API manufacturing facility in Minden, Germany, adding 100 m³ of reactor capacity and expanding its role as a global CDMO for small molecule drug substances. See our latest analysis for Siegfried Holding. Despite Siegfried Holding’s new API facility pointing to expanded capacity and customer demand, recent momentum has been weak, with the share price down 16.82% over 30 days and the 1 year total shareholder return down 28.36%,...

Sandoz Group (SWX:SDZ) has opened a new biosimilar development centre in Ljubljana, Slovenia, a fully digitally integrated US$99 million facility that expands its in house capabilities across drug substance and drug product development. See our latest analysis for Sandoz Group. Set against this investment in Ljubljana, Sandoz Group’s 1 day share price return declined 1.60% to CHF67.68, while its year to date share price return of 18.28% and 1 year total shareholder return of 57.12% suggest...

SoftwareOne Holding (SWX:SWON) has drawn fresh attention after announcing it is now an Anthropic Authorized Reseller for Amazon Bedrock and a Registered Anthropic Services Partner, giving clients access to Claude in secure enterprise cloud environments. See our latest analysis for SoftwareOne Holding. Despite the Anthropic partnership, SoftwareOne Holding’s latest share price of CHF7.98 reflects mixed momentum, with the 90 day share price return up 19.92% but the year to date share price...

Montana Aerospace (SWX:AERO) is in focus after its role in developing hybrid metal composite aerostructure components for future aircraft, including Airbus’ Wing of Tomorrow and the Boeing 737 MAX programs, drew fresh investor attention. See our latest analysis for Montana Aerospace. Despite the latest aerospace program wins, Montana Aerospace’s share price has fallen 18.25% over the past 90 days and 28.85% year to date, yet its 3-year total shareholder return of 54.36% points to a very...

Belimo Holding (SWX:BEAN) moved sharply higher after Morgan Stanley upgraded the stock, citing robust anticipated growth in the company’s data center cooling operations linked to expanding AI infrastructure demand. See our latest analysis for BELIMO Holding. At a share price of CHF965.5, BELIMO Holding has seen strong recent momentum, with a 30 day share price return of 27.54% and a 90 day return of 54.85%. The 1 year total shareholder return of 23.37% and 5 year total shareholder return of...

In recent days, UBS Group expanded its US wealth management footprint by hiring multiple advisor teams in key hubs such as Nashville, Washington, D.C., Philadelphia, and Fort Lauderdale, including Philadelphia-based advisor Adam Conish, who oversees about US$1.20 billion in client assets. Alongside these hires, UBS strengthened its leadership bench in sustainability and asset management, signaling a focus on climate risk oversight and fee-generating institutional relationships that could...

The European stock market has shown mixed results recently, with the pan-European STOXX Europe 600 Index rising slightly by 0.62% amid varied macroeconomic data and geopolitical developments. Amidst these fluctuations, identifying stocks that are priced below their intrinsic value can offer potential opportunities for investors looking to capitalize on market inefficiencies. In this context, understanding a stock's intrinsic value relative to its current price is crucial in assessing whether...

Adecco Group (SWX:ADEN) is in focus after reporting more than one million AI powered candidate interactions across ten countries, with its AI agents now supporting seven stages of the recruitment lifecycle. See our latest analysis for Adecco Group. The AI milestone comes after a challenging period for Adecco Group shares, with the 1-year total shareholder return down 30.12% and the year to date share price return down 32.61%, while the more recent 30-day share price return of 2.26% hints at...

Burckhardt Compression Holding (SWX:BCHN) issued new earnings guidance for fiscal 2026, projecting group sales between CHF 900 million and CHF 1,000 million and an EBIT margin of around 12%. See our latest analysis for Burckhardt Compression Holding. Burckhardt Compression Holding shares have recently picked up, with a 7 day share price return of 6.78% after the new 2026 guidance. However, the year to date share price return is still down 9.96% and the 1 year total shareholder return has...

Why Sika stock is in focus after Belgian expansion and survey results Sika (SWX:SIKA) has drawn fresh attention after commissioning a new concrete admixtures plant and technical center in Ham, Belgium, alongside reporting strong 2026 global employee engagement scores. See our latest analysis for Sika. The new Belgian facility and strong 2026 survey results arrive while Sika’s share price has gained momentum in the short term, with a 30 day share price return of 15.13% and 90 day share price...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Bystronic AG ( VTX:BYS ), is not the largest company out there, but it received a lot of attention from a substantial...

As European markets navigate mixed signals ahead of the European Central Bank's interest rate decision, investor sentiment has shown signs of improvement with hopes for geopolitical resolutions. Investing in penny stocks—while the term might seem outdated—still holds relevance as these smaller or newer companies can present unique growth opportunities. With a focus on financial health and potential stability, this article will spotlight three European penny stocks that could offer compelling...

Julius Bär Gruppe (SWX:BAER) recently issued €500 million of 5-year senior unsecured notes via Dutch vehicle ELM B.V., a funding move aimed at broadening access to euro liquidity and institutional investors. See our latest analysis for Julius Bär Gruppe. The stock has shown firm momentum recently, with a 2.04% 1 day share price return and 11.29% 90 day share price return, while the 1 year total shareholder return of 30.58% points to stronger gains for longer term holders. If the funding move...

Goldman Sachs upgrade puts Flughafen Zürich in focus Goldman Sachs has upgraded Flughafen Zürich (SWX:FHZN) to Buy, highlighting what it describes as a supportive investment profile as geopolitical reopening broadens and potentially influences traffic across key European airports. See our latest analysis for Flughafen Zürich. The upgrade comes after a sharp rebound in market sentiment, with the share price up 13.48% over the past month and 7.24% over the past week. The 1 year total...

Lonza Group (SWX:LONN) has signed fresh licensing agreements with Antharis Therapeutics and Stipple Bio, giving both biotechnology partners access to its antibody drug conjugate technology for oncology programs and positioning Lonza as a key supplier. See our latest analysis for Lonza Group. These oncology licensing deals arrive as the stock posts a 5.45% 1 month share price return and a 0.96% 1 day gain, while the 1 year total shareholder return is down 11.78%. This points to improving short...

Cosmo N.V. has recently announced that its partner InfectoPharm has launched Winlevi, a first-in-class topical acne cream using clascoterone, in Austria and Germany following European Commission approval. This rollout deepens Cosmo’s dermatology footprint in Europe and highlights the commercial potential of its role as exclusive global manufacturer of Winlevi. We’ll now examine how Winlevi’s European rollout, including the Austria and Germany launches, could influence Cosmo’s broader...

Voter approval clears path for Lebensraum Metalli Zug Estates Holding (SWX:ZUGN) is moving ahead with its Lebensraum Metalli project after Zug voters approved the Metalli development plan, a decision that gives investors clearer sightlines on future project driven opportunities. See our latest analysis for Zug Estates Holding. Despite the positive Metalli vote, the stock’s recent momentum has cooled, with the 30 day share price return down 6.33% and the 90 day move down 11.91%. However, the 3...